Reishi mushroom

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from Reishi)
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Reishi or ganoderma lucidum or lingzhi is a mushroom of the Ganodermataceae family and contain much triterpene, which works against inflammation. Reishi mushrooms have a similar effect to cortisone but help the body in a natural way.[citation needed] Reishi activates and supports the immune system.[1] Iwatsuki et al. (2013) found reishi inhibits the activation of Epstein-Barr virus.[2]

ME/CFS[edit | edit source]

Evidence[edit | edit source]

It is used in the treatment regime against ME of Ms Katrina Voss to prevent the use of Raltegravir.

A small trial by Soksawatmakhin et al. (2013) found that a dose of 500mg or reishi extract four times per day resulted in a clinically significant improvement in patients with unexplained chronic fatigue meeting the NICE guidelines criteria for CFS/ME.[3]

Notable studies[edit | edit source]

  • 2013, Preliminary study of the applications of Ganoderma lucidum in chronic fatigue syndrome[3](Full text)

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. Ganoderma — A Therapeutic Fungal Biofactory
  2. Iwatsuki, Kenji; Akihisa, Toshihiro; Tokuda, Harukuni; Ukiya, Motohiko; Oshikubo, Manabu; Kimura, Yumiko; Asano, Takeshi; Nomura, Atsushi; Nishino, Hoyoku (December 2003). "Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation". Journal of Natural Products. 66 (12): 1582–1585. doi:10.1021/np0302293. ISSN 0163-3864. PMID 14695801.
  3. 3.0 3.1 Soksawatmakhin, Sukanya; Boonyahotra, Wijit (January 2013). "Preliminary study of the applications of Ganoderma lucidum in chronic fatigue syndrome". Journal of Asian Association of Schools of Pharmacy. 2: 262–268. ISSN 0975-6299.